Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis

ClinicalTrials.gov ID: NCT03200912

Public ClinicalTrials.gov record NCT03200912. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Randomized Doubleblind Vehicle-controlled Parallel Comparison Study to Determine Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.015% and Picato® Gel 0.015% in Subjects With Actinic Keratosis on the Face or Scalp

Study identification

NCT ID
NCT03200912
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Actavis Inc.
Industry
Enrollment
507 participants

Conditions and interventions

Interventions

  • Ingenol Mebutate (Picato®) Drug
  • Generic Ingenol Mebutate Drug
  • Vehicle Foam Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 95 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 18, 2016
Primary completion
Mar 6, 2017
Completion
Mar 21, 2017
Last update posted
Jan 13, 2020

2016 – 2017

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
Dermatology Specialists, Inc. Oceanside California 92056
Horizons Clinical Research Ctr., LLC Denver Colorado 80220
The Center for Clinical and Cosmetic Research Aventura Florida 33180
Moore Clinical Research Brandon Florida 33511
Savin Medical Group Research Center Miami Lakes Florida 33014
Tory P. Sullivan, M.D., P.A. North Miami Beach Florida 33162
MedaPhase, Inc. Newnan Georgia 30263
Northwest Clinical Trials, Inc. Boise Idaho 83704
Arlington Dermatology Arlington Heights Illinois 60005
Christie Clinic, LLC Champaign Illinois 61820
University Dermatology & Vein Clinic, LLC Darien Illinois 60561
Forefront Dermatology Carmel Indiana 46032
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256
The Indiana Clinical Trials Center Plainfield Indiana 46168
The South Bend Clinic,LLC South Bend Indiana 46617
Minnesota Clinical Study Center Fridley Minnesota 55432
MediSearch Clinical Trials Saint Joseph Missouri 64506
Academic Dermatology Associates Albuquerque New Mexico 87106
Dermatology Consulting Services High Point North Carolina 27262
Omega Medical Research, 400 Bald Hill Road, Warwick, RI 02886 Warwick Rhode Island 02886
Palmetto Clinical Trial Services Fountain Inn South Carolina 29644
Dermatology Associates of Knoxville, PC Knoxville Tennessee 37917
DermReseach New Braunfels New Braunfels Texas 78130

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03200912, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 13, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03200912 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →